Liver Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Regional Liver Unit, The Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.
Regional Liver Unit, The Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom.
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1364-1371.e3. doi: 10.1016/j.cgh.2018.10.044. Epub 2018 Oct 31.
BACKGROUND & AIMS: Dietary interventions for weight loss are effective therapies for nonalcoholic fatty liver disease (NAFLD). The Mediterranean diet might benefit these patients, but it is not followed consistently in Northern European countries. We examined factors that determine Mediterranean diet adoption and maintenance in a northern European population.
We used a mixed-methods approach to investigate the effects of a 12-week Mediterranean diet intervention and perceived barriers and facilitators. Nineteen adults with NAFLD were recruited from a tertiary hepatology center in England. Participants were taught behavioral strategies through the provision of shopping lists, meal planners, and recipes; no advice was given on calorie allowances or physical activities. We used the 14-point Mediterranean diet assessment tool to assess dietary intake, based on a small number of foods in servings per day or servings per week, at baseline and after 12 weeks; participants were assigned scores of low (<5 points), moderate (6-9 points), or high (10-14 points). Semistructured interviews were audiorecorded, transcribed, and analyzed using the framework method.
Twelve weeks after the dietary advice, Mediterranean diet adoption significantly increased from moderate to high (mean increase, 2.2 points; from 7.6 ± 2.5 at baseline to 9.8 ± 2.8 at 12 wk) (P = .006). This increase was associated with a mean reduction in body weight of 2.4 kg (from 99.2 ± 17.0 kg at baseline to 96.8 ± 17.5 kg at 12 wk) (P = .001) and increased serum concentrations of high-density lipoprotein cholesterol in 72% of participants (from 1.10 ± 0.8 at baseline to 1.20 ± 1.30 vs 1.00 ± 0.5 at 12 wk) (P = .009). Increased nutrition knowledge and skills, family support, Mediterranean diet promotion in media and clinical settings, and nutritional care facilitated diet changes. Barriers to Mediterranean diet uptake included an obesogenic environment, life stressors, and demand for convenience. Poor understanding of the causes and significance of NAFLD adversely affected readiness to change dietary habits.
In an analysis of patients with NAFLD in the northern United Kingdom, we found a 12-week Mediterranean diet intervention was acceptable and associated with significant reductions in body weight and increased serum levels of high-density lipoprotein. We identified barriers and facilitators that could support appropriate treatment adaptations and guide personalized intervention approaches.
对于非酒精性脂肪性肝病(NAFLD)患者来说,饮食干预减肥是一种有效的治疗方法。地中海饮食可能对这些患者有益,但在北欧国家并不经常遵循。我们研究了决定北欧人群采用和维持地中海饮食的因素。
我们使用混合方法研究了为期 12 周的地中海饮食干预以及感知到的障碍和促进因素的影响。从英国一家三级肝病中心招募了 19 名患有 NAFLD 的成年人。通过提供购物清单、膳食计划和食谱,向参与者传授行为策略;没有就卡路里摄入量或体育活动提供建议。我们使用 14 分地中海饮食评估工具,根据每天或每周的食物份数来评估饮食摄入量,在基线和 12 周后进行评估;参与者的分数为低(<5 分)、中(6-9 分)或高(10-14 分)。半结构化访谈进行录音、转录,并使用框架方法进行分析。
在饮食建议后的 12 周,地中海饮食的采用从中等增加到高(平均增加 2.2 分;从基线时的 7.6 ± 2.5 增加到 12 周时的 9.8 ± 2.8)(P =.006)。这一增加与体重平均下降 2.4 公斤(从基线时的 99.2 ± 17.0 公斤降至 12 周时的 96.8 ± 17.5 公斤)(P =.001)以及 72%的参与者血清高密度脂蛋白胆固醇浓度增加有关(从基线时的 1.10 ± 0.8 增加到 1.20 ± 1.30 与 12 周时的 1.00 ± 0.5 相比)(P =.009)。营养知识和技能的提高、家庭支持、媒体和临床环境中对地中海饮食的推广以及营养护理促进了饮食的改变。地中海饮食的采用障碍包括肥胖环境、生活压力源和对便利性的需求。对 NAFLD 的病因和意义的理解不足会对改变饮食习惯的准备情况产生不利影响。
在对英国北部的 NAFLD 患者进行的分析中,我们发现为期 12 周的地中海饮食干预是可以接受的,并且与体重显著减轻和血清高密度脂蛋白水平升高有关。我们确定了可以支持适当治疗调整和指导个性化干预方法的障碍和促进因素。